Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge. - sprookjes - yvandenbroek - TriplyDB

Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.

Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.

http://www.wikidata.org/entity/Q40165519

about

Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus New perspectives for preventing hepatitis C virus liver graft infection.Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates.Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein.Conformational Flexibility in the CD81-Binding Site of the Hepatitis C Virus Glycoprotein E2.Novel methods to prevent HCV transmission

P2860

Q28552909-51E8CCA2-2339-48E7-A803-22D6103D31B7 Q28604286-8220E4BD-194C-4A52-B2D0-B5B280192E42 Q37015805-C6FEC1C0-ED97-4560-8D56-F259E78D360A Q37252935-45BCB327-A76E-456F-917B-61286AA2C0D1 Q37415463-2BF5FB62-8585-4720-9472-CF64DD255715 Q38758212-F4DBC907-47E5-41C5-9454-1012F4E97AB4 Q40248234-409EFCF0-BBED-4143-9DB7-52E2EC72937A Q45324948-40444D4D-9D3E-4005-92D3-E0F31D4BA6BB Q45325612-E80CD052-8EFD-43A4-86BC-FB1DC7D9488F Q55299977-08898C87-30E8-4E17-9065-EE478975210E Q55383950-62EC7145-19BA-42E6-994A-D9EB52034FF6 Q58439383-B7132188-CC37-4784-821D-C56B088C746D

P2860

Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.

http://www.wikidata.org/entity/Q40165519

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Monoclonal anti-envelope antib ...... d hepatitis C virus challenge.

@en

type

label

Monoclonal anti-envelope antib ...... d hepatitis C virus challenge.

@en

prefLabel

Monoclonal anti-envelope antib ...... d hepatitis C virus challenge.

@en

P1433

Q40165519-EBBE644F-2F3B-4032-A168-1F9E90BD5EBA

P1476

Q40165519-B6383E50-F55C-4060-BBDC-62BFE59B560C

P2093

Q40165519-14B62377-8157-4FB5-B29D-3388A26EB274

Q40165519-3EF32EC8-6219-44C1-8DE4-0EDAB16EF980

Q40165519-69FF5071-90E2-4159-BD8C-679B291E82BB

Q40165519-6AEB0BD3-3860-401C-A525-5F7C0C5428DD

Q40165519-905F2EEB-E10D-4C65-B598-ACE7F0595B39

Q40165519-93F5E1A8-1354-45AD-BC37-3336938B2313

Q40165519-CB1D662C-FBB3-4813-B286-134819484621

Q40165519-D527C7F8-06D5-4C28-AB47-CA9503A96830

Q40165519-E5D371B2-C021-47D4-AB7F-53BE6F3DAF8B

Q40165519-FC96084E-EB7D-49A8-9C1F-410F47695E9D

P2860

Q40165519-0B0B12C6-32C1-4099-9592-AAE1575AFEA0

Q40165519-10B9E4B1-850D-4404-B0AF-2F8709CA7DC3

Q40165519-16117C24-B77D-40EA-A665-1D14C7A86303

Q40165519-1630D4CC-8651-41B2-917A-7D01DF53C3E7

Q40165519-17FEB2DB-6DE4-4971-B7ED-0E7286C17465

Q40165519-1C4B0974-1575-465B-A6BF-EEA015E17CE5

Q40165519-1DB60705-8AC4-485E-9D39-999F164D7BC3

Q40165519-234E69B0-7E78-494A-88CA-7B8211C0C83C

Q40165519-260B90D3-F44C-4273-8CAB-0E050F94451F

Q40165519-32528D65-3146-40A8-85BC-4871D5D02738

P304

Q40165519-6D617AAE-0992-4228-8016-F3E53EDE75E2

P31

Q40165519-700BB925-F1FD-4CFB-BFF5-7C7DE6BE5C24

P356

Q40165519-D63B850B-D18B-4D6A-979D-504E42470A3C

P407

Q40165519-4CF3F299-485E-4A6B-B217-30FD9A4B9C17

P433

Q40165519-9A393097-3BE9-4E93-9ADD-77EFF93B71AC

P478

Q40165519-C1459F26-FB67-4004-9327-38EFB71E4375

P50

Q40165519-9984276C-F9B7-4701-A89C-78E0A95F7888

Q40165519-F95EBC46-1C15-4717-B7D0-F79634E54005

P577

Q40165519-EE214AE6-CC32-40FF-AA0B-D17D15CCB08E

P5875

Q40165519-E1134EF3-A855-4B2B-9C6E-1E03D18318F4

P698

Q40165519-D31EFB68-0553-4F64-8FBB-320C0E37CC20

P356

P1433

P1476

Monoclonal anti-envelope antib ...... d hepatitis C virus challenge.

@en

P2093

Ali Farhoudi

http://www.w3.org/2001/XMLSchema#string

Arvind H Patel

http://www.w3.org/2001/XMLSchema#string

Freya Van Houtte

http://www.w3.org/2001/XMLSchema#string

Isabelle Desombere

http://www.w3.org/2001/XMLSchema#string

Jane A McKeating

http://www.w3.org/2001/XMLSchema#string

Laura Heydmann

http://www.w3.org/2001/XMLSchema#string

Lieven Verhoye

http://www.w3.org/2001/XMLSchema#string

Patrick Pessaux

http://www.w3.org/2001/XMLSchema#string

Samira Fafi-Kremer

http://www.w3.org/2001/XMLSchema#string

Sarah Cole

http://www.w3.org/2001/XMLSchema#string

P2860

Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus

In vitro selection of a neutralization-resistant hepatitis C virus escape mutant

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

Structure of Hepatitis C Virus Envelope Glycoprotein E2 Antigenic Site 412 to 423 in Complex with Antibody AP33

Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody

P304

1120-1134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.28428

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Philip Meuleman

Geert Leroux-Roels

P577

2015-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

288663574

http://www.w3.org/2001/XMLSchema#string

P698

26710081

http://www.w3.org/2001/XMLSchema#string